These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 32087145)
1. Psychosocial Predictors of Glaucoma Medication Adherence Among the Support, Educate, Empower (SEE) Personalized Glaucoma Coaching Pilot Study Participants. Salman M; Andrews C; Heisler M; Darnley-Fisch D; Newman-Casey PA Am J Ophthalmol; 2020 Aug; 216():207-218. PubMed ID: 32087145 [TBL] [Abstract][Full Text] [Related]
2. The Impact of the Support, Educate, Empower Personalized Glaucoma Coaching Pilot Study on Glaucoma Medication Adherence. Newman-Casey PA; Niziol LM; Lee PP; Musch DC; Resnicow K; Heisler M Ophthalmol Glaucoma; 2020; 3(4):228-237. PubMed ID: 33012330 [TBL] [Abstract][Full Text] [Related]
3. Demographic, Clinical, and Psychosocial Predictors of Change in Medication Adherence in the Support, Educate, Empower Program. Miller DJ; Niziol LM; Elam AR; Heisler M; Lee PP; Resnicow K; Musch DC; Darnley-Fisch D; Mitchell J; Newman-Casey PA Ophthalmol Glaucoma; 2022; 5(1):47-57. PubMed ID: 34098169 [TBL] [Abstract][Full Text] [Related]
4. Patient Experience during the Support, Educate, Empower Glaucoma Coaching Program to Improve Medication Adherence: A Pilot Study. Hollenhorst CN; Elliott V; Heisler M; Schneider K; Resnicow K; Newman-Casey PA Ophthalmol Glaucoma; 2020; 3(4):238-252. PubMed ID: 33008556 [TBL] [Abstract][Full Text] [Related]
5. Glaucoma Medication Adherence 1 Year after the Support, Educate, Empower Personalized Glaucoma Coaching Program. Killeen OJ; Niziol LM; Cho J; Heisler M; Resnicow K; Darnley-Fisch D; Musch DC; Lee PP; Newman-Casey PA Ophthalmol Glaucoma; 2023; 6(1):23-28. PubMed ID: 35953021 [TBL] [Abstract][Full Text] [Related]
6. Increased Near Activities Function Associated With Increased Glaucoma Medication Adherence Among Support, Educate, Empower (SEE) Participants. Cho J; Niziol LM; Heisler M; Newman-Casey PA J Glaucoma; 2021 Aug; 30(8):744-749. PubMed ID: 33675338 [TBL] [Abstract][Full Text] [Related]
7. Impact of the Support, Educate, Empower Personalized Glaucoma Coaching Program Pilot Study on Eye Drop Instillation Technique and Self-Efficacy. Schneider KJ; Hollenhorst CN; Valicevic AN; Niziol LM; Heisler M; Musch DC; Cain SM; Newman-Casey PA Ophthalmol Glaucoma; 2021; 4(1):42-50. PubMed ID: 32781286 [TBL] [Abstract][Full Text] [Related]
9. Patient-Centered Outcomes After a Medication Adherence Intervention: a Pilot Study. Cho J; Song M; Niziol LM; Heisler M; Resnicow K; Musch DC; Lee P; Darnley-Fisch D; Newman-Casey PA J Glaucoma; 2023 Oct; 32(10):891-899. PubMed ID: 37054438 [TBL] [Abstract][Full Text] [Related]
11. The Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey. Newman-Casey PA; Robin AL; Blachley T; Farris K; Heisler M; Resnicow K; Lee PP Ophthalmology; 2015 Jul; 122(7):1308-16. PubMed ID: 25912144 [TBL] [Abstract][Full Text] [Related]
12. Accuracy of Patient-reported Adherence to Glaucoma Medications on a Visual Analog Scale Compared With Electronic Monitors. Sayner R; Carpenter DM; Blalock SJ; Robin AL; Muir KW; Hartnett ME; Giangiacomo AL; Tudor G; Sleath B Clin Ther; 2015 Sep; 37(9):1975-85. PubMed ID: 26164785 [TBL] [Abstract][Full Text] [Related]
13. Predicting Adherence With the Glaucoma Treatment Compliance Assessment Tool. Sanchez FG; Mansberger SL; Newman-Casey PA J Glaucoma; 2020 Nov; 29(11):1017-1024. PubMed ID: 32740508 [TBL] [Abstract][Full Text] [Related]
14. The Impact of the Coronavirus Disease 2019 Pandemic on Adherence to Ocular Hypotensive Medication in Patients with Primary Open-Angle Glaucoma. Racette L; Abu SL; Poleon S; Thomas T; Sabbagh N; Girkin CA Ophthalmology; 2022 Mar; 129(3):258-266. PubMed ID: 34673098 [TBL] [Abstract][Full Text] [Related]
15. Adherence to Ocular Hypotensive Medication in Patients With Primary Open Angle Glaucoma in Ghana. Kyei S; Kwao E; Mashige PK; Listowell Abu S; Racette L J Glaucoma; 2023 Sep; 32(9):777-782. PubMed ID: 37079490 [TBL] [Abstract][Full Text] [Related]
16. Patterns of Glaucoma Medication Adherence over Four Years of Follow-Up. Newman-Casey PA; Blachley T; Lee PP; Heisler M; Farris KB; Stein JD Ophthalmology; 2015 Oct; 122(10):2010-21. PubMed ID: 26319441 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Medication Adherence Assessment Tools to Identify Glaucoma Medication Nonadherence. Cho J; Niziol LM; Lee PP; Heisler M; Resnicow K; Musch DC; Newman-Casey PA Ophthalmol Glaucoma; 2022; 5(2):137-145. PubMed ID: 34358735 [TBL] [Abstract][Full Text] [Related]
18. An exploratory study of factors influencing glaucoma treatment adherence. Stryker JE; Beck AD; Primo SA; Echt KV; Bundy L; Pretorius GC; Glanz K J Glaucoma; 2010 Jan; 19(1):66-72. PubMed ID: 20075676 [TBL] [Abstract][Full Text] [Related]
19. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study. Boland MV; Chang DS; Frazier T; Plyler R; Friedman DS JAMA Ophthalmol; 2014 Jul; 132(7):838-44. PubMed ID: 24830878 [TBL] [Abstract][Full Text] [Related]
20. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma. Friedman DS; Okeke CO; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Quigley HA Ophthalmology; 2009 Jun; 116(6):1097-105. PubMed ID: 19376591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]